Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
about
Colistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health PerspectivesIdentification of Outer Membrane and Exoproteins of Carbapenem-Resistant Multilocus Sequence Type 258 Klebsiella pneumoniaeThe role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae.Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes.Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.KPC-producing Klebsiella pneumoniae strains that harbor AAC(6')-Ib exhibit intermediate resistance to amikacin.Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia.Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia IsolatesCarbapenemase-producing Enterobacteriaceae.Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem ResistanceEffects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae.Genomically Informed Surveillance for Carbapenem-Resistant Enterobacteriaceae in a Health Care SystemStepwise evolution of pandrug-resistance in Klebsiella pneumoniae.Optimizing Polymyxin Combinations Against Resistant Gram-Negative BacteriaWhole genome sequence of Klebsiella pneumoniae U25, a hypermucoviscous, multidrug resistant, biofilm producing isolate from India.Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniaeIn vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use.Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia.Identification of IS1R and IS10R elements inserted into ompk36 porin gene of two multidrug-resistant Klebsiella pneumoniae hospital strains.Environmental and genetic modulation of the phenotypic expression of antibiotic resistance.Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains.In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases.Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.Treatment of Hospital or Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Enterobacteriaceae: Leveraging Molecular Resistance Testing and Combination Therapy to Improve Outcomes.Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae.Whole genome and transcriptome analysis reveal MALDI-TOF MS and SDS-PAGE have limited performance for the detection of the key outer membrane protein in carbapenem-resistant Klebsiella pneumoniae isolates.Monitoring microevolution of OXA-48-producing Klebsiella pneumoniae ST147 in a hospital setting by SMRT sequencing.Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae.Complement Susceptibility in Relation to Genome Sequence of Recent Klebsiella pneumoniae Isolates from Thai Hospitals
P2860
Q28076261-694D66CC-3E78-43A3-841D-369DC8F87966Q28546573-D6FC9EA8-130A-4918-AFA6-259C0181E1B3Q30300020-7255589D-6176-4F8A-B4B5-7AF0E19909CFQ30356154-4E6A430E-E17C-479E-9348-8FFA3FB1E3B7Q33797981-A66BECF3-5970-40E6-95FB-09EF6F1D001AQ34058006-8BB65C2D-9757-4128-9CFE-648FAA0C951BQ34597573-5D6B2D29-EC6E-4BCB-AFEA-FE0E7F7A6E21Q35076943-3DFC99AF-8D1C-4E77-BFC8-98C3A60DEB6EQ35661664-96821780-AE0F-43E2-9FBB-DE987A679C5FQ35751615-8D2327CC-06E2-4E26-907D-F83A53CB9AC8Q35860134-92E55B01-5424-4517-9D63-B10679DC1892Q35960957-2A15389A-9C47-4377-A505-36E92D6C4D3DQ36002662-5194C519-FBD1-45D3-BC9D-B5130FBB78A6Q36174574-51DD8AB8-1DB9-4B1E-9315-DD0EB01B5C64Q36363261-351EA634-9062-48CF-B951-E476BFF3D340Q36571083-1697B300-9F74-49E3-B673-A61D05257E0DQ36887935-36489926-2810-4037-BE2A-1E5044BAC016Q37544741-5E3A00B4-7754-420D-A1A1-A04F4B6DE7C2Q37562099-4F955AD6-C914-4066-86EF-3F961DCC3403Q38755686-755FD31A-4E2A-40EA-9247-6A7686C18670Q38840588-7A1FCE1F-F47E-4E0E-9125-3B215619C0B4Q39195574-270375D3-A031-4905-A1AB-1031CCA2B8C4Q40125157-E5BEF855-974D-4B11-B9AD-A2DF598425FBQ40315371-80B3142C-13EC-4384-81F7-4DBC0AFC1C30Q40342728-ACA7B0F1-FE26-4F7F-82D3-93927555D333Q40598620-F6293440-383D-4548-BC35-DE344E16D85CQ40616155-674D9F07-8EAC-407C-9540-54EB0234949BQ42638031-182D0AE7-CCA8-421E-A25F-64F622A7E04CQ46264986-9E7A19F3-F88F-4497-97BE-CC22EB4EC003Q46306375-B650214D-34B1-488C-8F2B-FA573544F4DEQ47134224-4DBF950C-B2B3-4427-9C5F-97C1A5F63D22Q47229231-A19B6DF1-DD75-4461-82EB-B79671876A4AQ48255534-86BFD6DB-A2D3-49A1-9A23-E12E1502C704Q58599416-68CFAC3E-75CD-4B52-91A4-8A008741F901
P2860
Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mutations of the ompK36 porin ...... ipenem and doripenem-colistin.
@en
Mutations of the ompK36 porin ...... ipenem and doripenem-colistin.
@nl
type
label
Mutations of the ompK36 porin ...... ipenem and doripenem-colistin.
@en
Mutations of the ompK36 porin ...... ipenem and doripenem-colistin.
@nl
prefLabel
Mutations of the ompK36 porin ...... ipenem and doripenem-colistin.
@en
Mutations of the ompK36 porin ...... ipenem and doripenem-colistin.
@nl
P2093
P2860
P356
P1476
Mutations of the ompK36 porin ...... ripenem and doripenem-colistin
@en
P2093
Annie N Farrell
Barry N Kreiswirth
Binghua Hao
Cornelius J Clancy
David S Perlin
Jae H Hong
Liang Chen
M Hong Nguyen
Ryan K Shields
Shaoji Cheng
P2860
P304
P356
10.1128/AAC.01069-13
P407
P50
P577
2013-08-12T00:00:00Z